nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—SLC28A3—Gemcitabine—breast cancer	0.244	1	CbGbCtD
Adenosine—Cytarabine—Gemcitabine—breast cancer	0.146	0.35	CrCrCtD
Adenosine—Azacitidine—Gemcitabine—breast cancer	0.139	0.333	CrCrCtD
Adenosine—Decitabine—Gemcitabine—breast cancer	0.132	0.317	CrCrCtD
Adenosine—SLC28A3—nipple—breast cancer	0.00367	0.0699	CbGeAlD
Adenosine—ADORA2B—nipple—breast cancer	0.00261	0.0498	CbGeAlD
Adenosine—ADK—mammary gland—breast cancer	0.00236	0.045	CbGeAlD
Adenosine—SLC28A3—adipose tissue—breast cancer	0.002	0.038	CbGeAlD
Adenosine—ADK—nipple—breast cancer	0.00195	0.0372	CbGeAlD
Adenosine—SLC28A3—bone marrow—breast cancer	0.00173	0.033	CbGeAlD
Adenosine—SLC28A3—female gonad—breast cancer	0.00167	0.0318	CbGeAlD
Adenosine—DPP4—embryo—breast cancer	0.00156	0.0298	CbGeAlD
Adenosine—ADORA2B—pituitary gland—breast cancer	0.00143	0.0272	CbGeAlD
Adenosine—ADORA2B—adipose tissue—breast cancer	0.00142	0.0271	CbGeAlD
Adenosine—ADA—adipose tissue—breast cancer	0.0013	0.0248	CbGeAlD
Adenosine—DPP4—epithelium—breast cancer	0.00128	0.0243	CbGeAlD
Adenosine—ADK—skin of body—breast cancer	0.00125	0.0238	CbGeAlD
Adenosine—ADA—female reproductive system—breast cancer	0.0012	0.0228	CbGeAlD
Adenosine—ADK—endometrium—breast cancer	0.00118	0.0225	CbGeAlD
Adenosine—ADA—adrenal gland—breast cancer	0.00117	0.0222	CbGeAlD
Adenosine—DPP4—endometrium—breast cancer	0.00114	0.0218	CbGeAlD
Adenosine—ADA—bone marrow—breast cancer	0.00113	0.0215	CbGeAlD
Adenosine—ADORA2A—female reproductive system—breast cancer	0.00109	0.0207	CbGeAlD
Adenosine—ADK—pituitary gland—breast cancer	0.00107	0.0203	CbGeAlD
Adenosine—ADK—adipose tissue—breast cancer	0.00106	0.0203	CbGeAlD
Adenosine—ADORA2A—adrenal gland—breast cancer	0.00106	0.0202	CbGeAlD
Adenosine—DPP4—uterus—breast cancer	0.00105	0.0201	CbGeAlD
Adenosine—DPP4—adipose tissue—breast cancer	0.00103	0.0196	CbGeAlD
Adenosine—ADORA1—adipose tissue—breast cancer	0.00102	0.0195	CbGeAlD
Adenosine—ADA—endocrine gland—breast cancer	0.00101	0.0193	CbGeAlD
Adenosine—ADK—female reproductive system—breast cancer	0.000977	0.0186	CbGeAlD
Adenosine—ADK—adrenal gland—breast cancer	0.000953	0.0182	CbGeAlD
Adenosine—DPP4—female reproductive system—breast cancer	0.000947	0.018	CbGeAlD
Adenosine—ADORA1—female reproductive system—breast cancer	0.000939	0.0179	CbGeAlD
Adenosine—DPP4—adrenal gland—breast cancer	0.000924	0.0176	CbGeAlD
Adenosine—ADK—bone marrow—breast cancer	0.000922	0.0176	CbGeAlD
Adenosine—ADORA2A—endocrine gland—breast cancer	0.000921	0.0175	CbGeAlD
Adenosine—DPP4—bone marrow—breast cancer	0.000894	0.017	CbGeAlD
Adenosine—ADK—female gonad—breast cancer	0.000889	0.0169	CbGeAlD
Adenosine—DPP4—female gonad—breast cancer	0.000862	0.0164	CbGeAlD
Adenosine—ADK—endocrine gland—breast cancer	0.000827	0.0158	CbGeAlD
Adenosine—DPP4—endocrine gland—breast cancer	0.000802	0.0153	CbGeAlD
Adenosine—ADORA1—endocrine gland—breast cancer	0.000795	0.0151	CbGeAlD
Adenosine—ADA—lymph node—breast cancer	0.000699	0.0133	CbGeAlD
Adenosine—Azacitidine—DNMT3A—breast cancer	0.00068	0.0927	CrCbGaD
Adenosine—Decitabine—DNMT3A—breast cancer	0.000664	0.0905	CrCbGaD
Adenosine—Adenosine triphosphate—ARAF—breast cancer	0.000622	0.0848	CrCbGaD
Adenosine—Azacitidine—CDA—breast cancer	0.000606	0.0827	CrCbGaD
Adenosine—ADK—lymph node—breast cancer	0.000572	0.0109	CbGeAlD
Adenosine—Tenofovir—NME1—breast cancer	0.000563	0.0768	CrCbGaD
Adenosine—DPP4—lymph node—breast cancer	0.000554	0.0106	CbGeAlD
Adenosine—ADORA1—lymph node—breast cancer	0.000549	0.0105	CbGeAlD
Adenosine—Adenosine monophosphate—PIM1—breast cancer	0.000412	0.0562	CrCbGaD
Adenosine—Azacitidine—DNMT1—breast cancer	0.000367	0.0501	CrCbGaD
Adenosine—Decitabine—DNMT1—breast cancer	0.000359	0.0489	CrCbGaD
Adenosine—Adenosine triphosphate—HSPA1B—breast cancer	0.000357	0.0487	CrCbGaD
Adenosine—Adenosine monophosphate—APRT—breast cancer	0.00035	0.0478	CrCbGaD
Adenosine—Cytarabine—CDA—breast cancer	0.000346	0.0472	CrCbGaD
Adenosine—Glucosamine—IFNG—breast cancer	0.000312	0.0426	CrCbGaD
Adenosine—Adenosine triphosphate—ACVR1—breast cancer	0.000304	0.0414	CrCbGaD
Adenosine—Glucosamine—MMP9—breast cancer	0.000199	0.0271	CrCbGaD
Adenosine—Adenosine triphosphate—ALK—breast cancer	0.000164	0.0224	CrCbGaD
Adenosine—S-Adenosylmethionine—COMT—breast cancer	0.000148	0.0202	CrCbGaD
Adenosine—Adenosine monophosphate—PDE4D—breast cancer	0.000144	0.0197	CrCbGaD
Adenosine—Glucosamine—TNF—breast cancer	0.000131	0.0178	CrCbGaD
Adenosine—Adenosine triphosphate—AKT1—breast cancer	0.000128	0.0175	CrCbGaD
Adenosine—Adenosine monophosphate—SRC—breast cancer	0.000126	0.0172	CrCbGaD
Adenosine—Adenosine triphosphate—ABL1—breast cancer	0.000121	0.0165	CrCbGaD
Adenosine—Clofarabine—ABCG2—breast cancer	0.00011	0.015	CrCbGaD
Adenosine—Anxiety—Paclitaxel—breast cancer	8.71e-05	0.000553	CcSEcCtD
Adenosine—Nausea—Tamoxifen—breast cancer	8.65e-05	0.000549	CcSEcCtD
Adenosine—Arrhythmia—Capecitabine—breast cancer	8.65e-05	0.000549	CcSEcCtD
Adenosine—Discomfort—Paclitaxel—breast cancer	8.64e-05	0.000548	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—breast cancer	8.63e-05	0.000548	CcSEcCtD
Adenosine—Cardiac arrest—Doxorubicin—breast cancer	8.58e-05	0.000544	CcSEcCtD
Adenosine—Pain—Gemcitabine—breast cancer	8.56e-05	0.000543	CcSEcCtD
Adenosine—Dry mouth—Paclitaxel—breast cancer	8.55e-05	0.000543	CcSEcCtD
Adenosine—Mood swings—Doxorubicin—breast cancer	8.55e-05	0.000542	CcSEcCtD
Adenosine—Asthenia—Thiotepa—breast cancer	8.54e-05	0.000542	CcSEcCtD
Adenosine—Dysgeusia—Docetaxel—breast cancer	8.52e-05	0.000541	CcSEcCtD
Adenosine—Nausea—Melphalan—breast cancer	8.47e-05	0.000538	CcSEcCtD
Adenosine—Back pain—Docetaxel—breast cancer	8.42e-05	0.000534	CcSEcCtD
Adenosine—Pain—Fluorouracil—breast cancer	8.42e-05	0.000534	CcSEcCtD
Adenosine—Anaphylactic shock—Paclitaxel—breast cancer	8.38e-05	0.000532	CcSEcCtD
Adenosine—Nausea—Goserelin—breast cancer	8.26e-05	0.000524	CcSEcCtD
Adenosine—Dysgeusia—Capecitabine—breast cancer	8.25e-05	0.000524	CcSEcCtD
Adenosine—Shock—Paclitaxel—breast cancer	8.25e-05	0.000523	CcSEcCtD
Adenosine—Dizziness—Vinorelbine—breast cancer	8.24e-05	0.000523	CcSEcCtD
Adenosine—Tachycardia—Paclitaxel—breast cancer	8.18e-05	0.000519	CcSEcCtD
Adenosine—Urticaria—Mitoxantrone—breast cancer	8.16e-05	0.000518	CcSEcCtD
Adenosine—Back pain—Capecitabine—breast cancer	8.15e-05	0.000517	CcSEcCtD
Adenosine—Hyperhidrosis—Paclitaxel—breast cancer	8.1e-05	0.000514	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—breast cancer	8.03e-05	0.000509	CcSEcCtD
Adenosine—Vision blurred—Capecitabine—breast cancer	7.94e-05	0.000504	CcSEcCtD
Adenosine—Vomiting—Vinorelbine—breast cancer	7.92e-05	0.000503	CcSEcCtD
Adenosine—Tremor—Capecitabine—breast cancer	7.9e-05	0.000501	CcSEcCtD
Adenosine—Dizziness—Thiotepa—breast cancer	7.87e-05	0.000499	CcSEcCtD
Adenosine—Rash—Vinorelbine—breast cancer	7.86e-05	0.000499	CcSEcCtD
Adenosine—Dermatitis—Vinorelbine—breast cancer	7.85e-05	0.000498	CcSEcCtD
Adenosine—Hypotension—Paclitaxel—breast cancer	7.83e-05	0.000497	CcSEcCtD
Adenosine—Urticaria—Fluorouracil—breast cancer	7.82e-05	0.000496	CcSEcCtD
Adenosine—Headache—Vinorelbine—breast cancer	7.81e-05	0.000495	CcSEcCtD
Adenosine—Syncope—Docetaxel—breast cancer	7.81e-05	0.000495	CcSEcCtD
Adenosine—Pollakiuria—Epirubicin—breast cancer	7.78e-05	0.000494	CcSEcCtD
Adenosine—Sweating—Methotrexate—breast cancer	7.7e-05	0.000488	CcSEcCtD
Adenosine—Palpitations—Docetaxel—breast cancer	7.69e-05	0.000488	CcSEcCtD
Adenosine—Loss of consciousness—Docetaxel—breast cancer	7.65e-05	0.000485	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Paclitaxel—breast cancer	7.64e-05	0.000485	CcSEcCtD
Adenosine—Cough—Docetaxel—breast cancer	7.6e-05	0.000482	CcSEcCtD
Adenosine—Hypersensitivity—Irinotecan—breast cancer	7.57e-05	0.00048	CcSEcCtD
Adenosine—Hypersensitivity—Mitoxantrone—breast cancer	7.57e-05	0.00048	CcSEcCtD
Adenosine—Vomiting—Thiotepa—breast cancer	7.57e-05	0.00048	CcSEcCtD
Adenosine—Syncope—Capecitabine—breast cancer	7.56e-05	0.00048	CcSEcCtD
Adenosine—Convulsion—Docetaxel—breast cancer	7.54e-05	0.000479	CcSEcCtD
Adenosine—Paraesthesia—Paclitaxel—breast cancer	7.53e-05	0.000478	CcSEcCtD
Adenosine—Hypertension—Docetaxel—breast cancer	7.52e-05	0.000477	CcSEcCtD
Adenosine—Drowsiness—Epirubicin—breast cancer	7.51e-05	0.000477	CcSEcCtD
Adenosine—Rash—Thiotepa—breast cancer	7.5e-05	0.000476	CcSEcCtD
Adenosine—Dermatitis—Thiotepa—breast cancer	7.5e-05	0.000476	CcSEcCtD
Adenosine—Dyspnoea—Paclitaxel—breast cancer	7.47e-05	0.000474	CcSEcCtD
Adenosine—Headache—Thiotepa—breast cancer	7.46e-05	0.000473	CcSEcCtD
Adenosine—Somnolence—Paclitaxel—breast cancer	7.45e-05	0.000473	CcSEcCtD
Adenosine—Palpitations—Capecitabine—breast cancer	7.45e-05	0.000473	CcSEcCtD
Adenosine—Chest pain—Docetaxel—breast cancer	7.41e-05	0.00047	CcSEcCtD
Adenosine—Loss of consciousness—Capecitabine—breast cancer	7.41e-05	0.00047	CcSEcCtD
Adenosine—Nausea—Vinorelbine—breast cancer	7.4e-05	0.00047	CcSEcCtD
Adenosine—Asthenia—Mitoxantrone—breast cancer	7.37e-05	0.000468	CcSEcCtD
Adenosine—Asthenia—Irinotecan—breast cancer	7.37e-05	0.000468	CcSEcCtD
Adenosine—Cough—Capecitabine—breast cancer	7.35e-05	0.000467	CcSEcCtD
Adenosine—Hypertension—Capecitabine—breast cancer	7.28e-05	0.000462	CcSEcCtD
Adenosine—Hypersensitivity—Fluorouracil—breast cancer	7.25e-05	0.00046	CcSEcCtD
Adenosine—Dry mouth—Docetaxel—breast cancer	7.25e-05	0.00046	CcSEcCtD
Adenosine—Sweating—Epirubicin—breast cancer	7.2e-05	0.000457	CcSEcCtD
Adenosine—Pollakiuria—Doxorubicin—breast cancer	7.2e-05	0.000457	CcSEcCtD
Adenosine—Asthenia—Gemcitabine—breast cancer	7.18e-05	0.000456	CcSEcCtD
Adenosine—Chest pain—Capecitabine—breast cancer	7.18e-05	0.000455	CcSEcCtD
Adenosine—Pain—Paclitaxel—breast cancer	7.17e-05	0.000455	CcSEcCtD
Adenosine—Anxiety—Capecitabine—breast cancer	7.15e-05	0.000454	CcSEcCtD
Adenosine—Anaphylactic shock—Docetaxel—breast cancer	7.1e-05	0.000451	CcSEcCtD
Adenosine—Discomfort—Capecitabine—breast cancer	7.09e-05	0.00045	CcSEcCtD
Adenosine—Nausea—Thiotepa—breast cancer	7.07e-05	0.000449	CcSEcCtD
Adenosine—Dry mouth—Capecitabine—breast cancer	7.02e-05	0.000445	CcSEcCtD
Adenosine—Shock—Docetaxel—breast cancer	6.99e-05	0.000444	CcSEcCtD
Adenosine—Drowsiness—Doxorubicin—breast cancer	6.95e-05	0.000441	CcSEcCtD
Adenosine—Tachycardia—Docetaxel—breast cancer	6.93e-05	0.00044	CcSEcCtD
Adenosine—Bradycardia—Epirubicin—breast cancer	6.87e-05	0.000436	CcSEcCtD
Adenosine—Dizziness—Irinotecan—breast cancer	6.8e-05	0.000431	CcSEcCtD
Adenosine—Shock—Capecitabine—breast cancer	6.77e-05	0.000429	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—breast cancer	6.72e-05	0.000426	CcSEcCtD
Adenosine—Tachycardia—Capecitabine—breast cancer	6.71e-05	0.000426	CcSEcCtD
Adenosine—Hypoaesthesia—Epirubicin—breast cancer	6.71e-05	0.000426	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—breast cancer	6.69e-05	0.000424	CcSEcCtD
Adenosine—Sweating—Doxorubicin—breast cancer	6.66e-05	0.000423	CcSEcCtD
Adenosine—Urticaria—Paclitaxel—breast cancer	6.66e-05	0.000423	CcSEcCtD
Adenosine—Hyperhidrosis—Capecitabine—breast cancer	6.65e-05	0.000422	CcSEcCtD
Adenosine—Hypotension—Docetaxel—breast cancer	6.64e-05	0.000421	CcSEcCtD
Adenosine—Vomiting—Mitoxantrone—breast cancer	6.53e-05	0.000415	CcSEcCtD
Adenosine—Vomiting—Irinotecan—breast cancer	6.53e-05	0.000415	CcSEcCtD
Adenosine—Dizziness—Fluorouracil—breast cancer	6.51e-05	0.000413	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—breast cancer	6.5e-05	0.000412	CcSEcCtD
Adenosine—Rash—Irinotecan—breast cancer	6.48e-05	0.000411	CcSEcCtD
Adenosine—Rash—Mitoxantrone—breast cancer	6.48e-05	0.000411	CcSEcCtD
Adenosine—Dermatitis—Mitoxantrone—breast cancer	6.47e-05	0.000411	CcSEcCtD
Adenosine—Dermatitis—Irinotecan—breast cancer	6.47e-05	0.000411	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Docetaxel—breast cancer	6.47e-05	0.000411	CcSEcCtD
Adenosine—Headache—Mitoxantrone—breast cancer	6.44e-05	0.000409	CcSEcCtD
Adenosine—Headache—Irinotecan—breast cancer	6.44e-05	0.000409	CcSEcCtD
Adenosine—Hypotension—Capecitabine—breast cancer	6.43e-05	0.000408	CcSEcCtD
Adenosine—Paraesthesia—Docetaxel—breast cancer	6.38e-05	0.000405	CcSEcCtD
Adenosine—Vomiting—Gemcitabine—breast cancer	6.37e-05	0.000404	CcSEcCtD
Adenosine—Bradycardia—Doxorubicin—breast cancer	6.35e-05	0.000403	CcSEcCtD
Adenosine—Dyspnoea—Docetaxel—breast cancer	6.33e-05	0.000402	CcSEcCtD
Adenosine—Cladribine—ABCG2—breast cancer	6.32e-05	0.00862	CrCbGaD
Adenosine—Somnolence—Docetaxel—breast cancer	6.32e-05	0.000401	CcSEcCtD
Adenosine—Rash—Gemcitabine—breast cancer	6.31e-05	0.000401	CcSEcCtD
Adenosine—Dermatitis—Gemcitabine—breast cancer	6.31e-05	0.0004	CcSEcCtD
Adenosine—Tinnitus—Epirubicin—breast cancer	6.29e-05	0.000399	CcSEcCtD
Adenosine—Headache—Gemcitabine—breast cancer	6.27e-05	0.000398	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Capecitabine—breast cancer	6.27e-05	0.000398	CcSEcCtD
Adenosine—Cardiac disorder—Epirubicin—breast cancer	6.26e-05	0.000397	CcSEcCtD
Adenosine—Flushing—Epirubicin—breast cancer	6.26e-05	0.000397	CcSEcCtD
Adenosine—Vomiting—Fluorouracil—breast cancer	6.26e-05	0.000397	CcSEcCtD
Adenosine—Hypoaesthesia—Doxorubicin—breast cancer	6.21e-05	0.000394	CcSEcCtD
Adenosine—Rash—Fluorouracil—breast cancer	6.21e-05	0.000394	CcSEcCtD
Adenosine—Dermatitis—Fluorouracil—breast cancer	6.2e-05	0.000393	CcSEcCtD
Adenosine—Paraesthesia—Capecitabine—breast cancer	6.18e-05	0.000392	CcSEcCtD
Adenosine—Hypersensitivity—Paclitaxel—breast cancer	6.18e-05	0.000392	CcSEcCtD
Adenosine—Headache—Fluorouracil—breast cancer	6.17e-05	0.000391	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—breast cancer	6.14e-05	0.00039	CcSEcCtD
Adenosine—Dyspnoea—Capecitabine—breast cancer	6.13e-05	0.000389	CcSEcCtD
Adenosine—Nausea—Irinotecan—breast cancer	6.1e-05	0.000387	CcSEcCtD
Adenosine—Nausea—Mitoxantrone—breast cancer	6.1e-05	0.000387	CcSEcCtD
Adenosine—Mediastinal disorder—Epirubicin—breast cancer	6.08e-05	0.000386	CcSEcCtD
Adenosine—Pain—Docetaxel—breast cancer	6.08e-05	0.000385	CcSEcCtD
Adenosine—Back pain—Methotrexate—breast cancer	6.07e-05	0.000385	CcSEcCtD
Adenosine—Arrhythmia—Epirubicin—breast cancer	6.03e-05	0.000382	CcSEcCtD
Adenosine—Asthenia—Paclitaxel—breast cancer	6.01e-05	0.000382	CcSEcCtD
Adenosine—Nausea—Gemcitabine—breast cancer	5.95e-05	0.000377	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—breast cancer	5.91e-05	0.000375	CcSEcCtD
Adenosine—Pain—Capecitabine—breast cancer	5.88e-05	0.000373	CcSEcCtD
Adenosine—Nausea—Fluorouracil—breast cancer	5.85e-05	0.000371	CcSEcCtD
Adenosine—Tinnitus—Doxorubicin—breast cancer	5.82e-05	0.000369	CcSEcCtD
Adenosine—Cardiac disorder—Doxorubicin—breast cancer	5.79e-05	0.000368	CcSEcCtD
Adenosine—Flushing—Doxorubicin—breast cancer	5.79e-05	0.000368	CcSEcCtD
Adenosine—Tension—Epirubicin—breast cancer	5.76e-05	0.000366	CcSEcCtD
Adenosine—Dysgeusia—Epirubicin—breast cancer	5.75e-05	0.000365	CcSEcCtD
Adenosine—Nervousness—Epirubicin—breast cancer	5.7e-05	0.000362	CcSEcCtD
Adenosine—Back pain—Epirubicin—breast cancer	5.68e-05	0.00036	CcSEcCtD
Adenosine—Mediastinal disorder—Doxorubicin—breast cancer	5.62e-05	0.000357	CcSEcCtD
Adenosine—Arrhythmia—Doxorubicin—breast cancer	5.58e-05	0.000354	CcSEcCtD
Adenosine—Dizziness—Paclitaxel—breast cancer	5.54e-05	0.000352	CcSEcCtD
Adenosine—Vision blurred—Epirubicin—breast cancer	5.53e-05	0.000351	CcSEcCtD
Adenosine—Cough—Methotrexate—breast cancer	5.47e-05	0.000347	CcSEcCtD
Adenosine—Urticaria—Capecitabine—breast cancer	5.46e-05	0.000347	CcSEcCtD
Adenosine—Convulsion—Methotrexate—breast cancer	5.44e-05	0.000345	CcSEcCtD
Adenosine—Agitation—Epirubicin—breast cancer	5.4e-05	0.000342	CcSEcCtD
Adenosine—Chest pain—Methotrexate—breast cancer	5.34e-05	0.000339	CcSEcCtD
Adenosine—Tension—Doxorubicin—breast cancer	5.33e-05	0.000338	CcSEcCtD
Adenosine—Vomiting—Paclitaxel—breast cancer	5.33e-05	0.000338	CcSEcCtD
Adenosine—Dysgeusia—Doxorubicin—breast cancer	5.32e-05	0.000338	CcSEcCtD
Adenosine—Rash—Paclitaxel—breast cancer	5.28e-05	0.000335	CcSEcCtD
Adenosine—Dermatitis—Paclitaxel—breast cancer	5.28e-05	0.000335	CcSEcCtD
Adenosine—Discomfort—Methotrexate—breast cancer	5.28e-05	0.000335	CcSEcCtD
Adenosine—Nervousness—Doxorubicin—breast cancer	5.28e-05	0.000335	CcSEcCtD
Adenosine—Syncope—Epirubicin—breast cancer	5.27e-05	0.000334	CcSEcCtD
Adenosine—Back pain—Doxorubicin—breast cancer	5.26e-05	0.000333	CcSEcCtD
Adenosine—Headache—Paclitaxel—breast cancer	5.25e-05	0.000333	CcSEcCtD
Adenosine—Hypersensitivity—Docetaxel—breast cancer	5.23e-05	0.000332	CcSEcCtD
Adenosine—Palpitations—Epirubicin—breast cancer	5.19e-05	0.000329	CcSEcCtD
Adenosine—Loss of consciousness—Epirubicin—breast cancer	5.16e-05	0.000327	CcSEcCtD
Adenosine—Cough—Epirubicin—breast cancer	5.12e-05	0.000325	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—breast cancer	5.12e-05	0.000325	CcSEcCtD
Adenosine—Vision blurred—Doxorubicin—breast cancer	5.12e-05	0.000325	CcSEcCtD
Adenosine—Asthenia—Docetaxel—breast cancer	5.1e-05	0.000323	CcSEcCtD
Adenosine—Convulsion—Epirubicin—breast cancer	5.09e-05	0.000323	CcSEcCtD
Adenosine—Hypertension—Epirubicin—breast cancer	5.07e-05	0.000322	CcSEcCtD
Adenosine—Hypersensitivity—Capecitabine—breast cancer	5.07e-05	0.000322	CcSEcCtD
Adenosine—Chest pain—Epirubicin—breast cancer	5e-05	0.000317	CcSEcCtD
Adenosine—Agitation—Doxorubicin—breast cancer	4.99e-05	0.000317	CcSEcCtD
Adenosine—Anxiety—Epirubicin—breast cancer	4.98e-05	0.000316	CcSEcCtD
Adenosine—Nausea—Paclitaxel—breast cancer	4.98e-05	0.000316	CcSEcCtD
Adenosine—Hyperhidrosis—Methotrexate—breast cancer	4.95e-05	0.000314	CcSEcCtD
Adenosine—Discomfort—Epirubicin—breast cancer	4.94e-05	0.000313	CcSEcCtD
Adenosine—Asthenia—Capecitabine—breast cancer	4.94e-05	0.000313	CcSEcCtD
Adenosine—Dry mouth—Epirubicin—breast cancer	4.89e-05	0.00031	CcSEcCtD
Adenosine—Syncope—Doxorubicin—breast cancer	4.87e-05	0.000309	CcSEcCtD
Adenosine—Palpitations—Doxorubicin—breast cancer	4.8e-05	0.000305	CcSEcCtD
Adenosine—Anaphylactic shock—Epirubicin—breast cancer	4.79e-05	0.000304	CcSEcCtD
Adenosine—Hypotension—Methotrexate—breast cancer	4.78e-05	0.000304	CcSEcCtD
Adenosine—Loss of consciousness—Doxorubicin—breast cancer	4.78e-05	0.000303	CcSEcCtD
Adenosine—Cough—Doxorubicin—breast cancer	4.74e-05	0.000301	CcSEcCtD
Adenosine—Shock—Epirubicin—breast cancer	4.71e-05	0.000299	CcSEcCtD
Adenosine—Convulsion—Doxorubicin—breast cancer	4.71e-05	0.000299	CcSEcCtD
Adenosine—Dizziness—Docetaxel—breast cancer	4.7e-05	0.000298	CcSEcCtD
Adenosine—Hypertension—Doxorubicin—breast cancer	4.69e-05	0.000298	CcSEcCtD
Adenosine—Tachycardia—Epirubicin—breast cancer	4.68e-05	0.000297	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—breast cancer	4.67e-05	0.000296	CcSEcCtD
Adenosine—Hyperhidrosis—Epirubicin—breast cancer	4.63e-05	0.000294	CcSEcCtD
Adenosine—Chest pain—Doxorubicin—breast cancer	4.63e-05	0.000293	CcSEcCtD
Adenosine—Anxiety—Doxorubicin—breast cancer	4.61e-05	0.000292	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—breast cancer	4.6e-05	0.000292	CcSEcCtD
Adenosine—Discomfort—Doxorubicin—breast cancer	4.57e-05	0.00029	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—breast cancer	4.57e-05	0.00029	CcSEcCtD
Adenosine—Somnolence—Methotrexate—breast cancer	4.55e-05	0.000289	CcSEcCtD
Adenosine—Dizziness—Capecitabine—breast cancer	4.55e-05	0.000289	CcSEcCtD
Adenosine—Dry mouth—Doxorubicin—breast cancer	4.52e-05	0.000287	CcSEcCtD
Adenosine—Vomiting—Docetaxel—breast cancer	4.52e-05	0.000287	CcSEcCtD
Adenosine—Rash—Docetaxel—breast cancer	4.48e-05	0.000284	CcSEcCtD
Adenosine—Hypotension—Epirubicin—breast cancer	4.48e-05	0.000284	CcSEcCtD
Adenosine—Dermatitis—Docetaxel—breast cancer	4.48e-05	0.000284	CcSEcCtD
Adenosine—Headache—Docetaxel—breast cancer	4.45e-05	0.000282	CcSEcCtD
Adenosine—Anaphylactic shock—Doxorubicin—breast cancer	4.43e-05	0.000281	CcSEcCtD
Adenosine—Pain—Methotrexate—breast cancer	4.38e-05	0.000278	CcSEcCtD
Adenosine—Vomiting—Capecitabine—breast cancer	4.37e-05	0.000278	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Epirubicin—breast cancer	4.37e-05	0.000277	CcSEcCtD
Adenosine—Shock—Doxorubicin—breast cancer	4.36e-05	0.000277	CcSEcCtD
Adenosine—Rash—Capecitabine—breast cancer	4.34e-05	0.000275	CcSEcCtD
Adenosine—Dermatitis—Capecitabine—breast cancer	4.33e-05	0.000275	CcSEcCtD
Adenosine—Tachycardia—Doxorubicin—breast cancer	4.33e-05	0.000275	CcSEcCtD
Adenosine—Headache—Capecitabine—breast cancer	4.31e-05	0.000273	CcSEcCtD
Adenosine—Paraesthesia—Epirubicin—breast cancer	4.3e-05	0.000273	CcSEcCtD
Adenosine—Hyperhidrosis—Doxorubicin—breast cancer	4.29e-05	0.000272	CcSEcCtD
Adenosine—Dyspnoea—Epirubicin—breast cancer	4.27e-05	0.000271	CcSEcCtD
Adenosine—Somnolence—Epirubicin—breast cancer	4.26e-05	0.00027	CcSEcCtD
Adenosine—Nausea—Docetaxel—breast cancer	4.22e-05	0.000268	CcSEcCtD
Adenosine—Hypotension—Doxorubicin—breast cancer	4.14e-05	0.000263	CcSEcCtD
Adenosine—Pain—Epirubicin—breast cancer	4.1e-05	0.00026	CcSEcCtD
Adenosine—Nausea—Capecitabine—breast cancer	4.09e-05	0.000259	CcSEcCtD
Adenosine—Urticaria—Methotrexate—breast cancer	4.07e-05	0.000258	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Doxorubicin—breast cancer	4.04e-05	0.000256	CcSEcCtD
Adenosine—Paraesthesia—Doxorubicin—breast cancer	3.98e-05	0.000253	CcSEcCtD
Adenosine—Dyspnoea—Doxorubicin—breast cancer	3.95e-05	0.000251	CcSEcCtD
Adenosine—Somnolence—Doxorubicin—breast cancer	3.94e-05	0.00025	CcSEcCtD
Adenosine—Urticaria—Epirubicin—breast cancer	3.81e-05	0.000242	CcSEcCtD
Adenosine—Pain—Doxorubicin—breast cancer	3.79e-05	0.000241	CcSEcCtD
Adenosine—Hypersensitivity—Methotrexate—breast cancer	3.77e-05	0.000239	CcSEcCtD
Adenosine—Asthenia—Methotrexate—breast cancer	3.67e-05	0.000233	CcSEcCtD
Adenosine—Hypersensitivity—Epirubicin—breast cancer	3.53e-05	0.000224	CcSEcCtD
Adenosine—Urticaria—Doxorubicin—breast cancer	3.52e-05	0.000224	CcSEcCtD
Adenosine—Asthenia—Epirubicin—breast cancer	3.44e-05	0.000218	CcSEcCtD
Adenosine—Cytarabine—CYP3A4—breast cancer	3.43e-05	0.00468	CrCbGaD
Adenosine—Dizziness—Methotrexate—breast cancer	3.39e-05	0.000215	CcSEcCtD
Adenosine—Hypersensitivity—Doxorubicin—breast cancer	3.27e-05	0.000207	CcSEcCtD
Adenosine—Vomiting—Methotrexate—breast cancer	3.26e-05	0.000207	CcSEcCtD
Adenosine—Rash—Methotrexate—breast cancer	3.23e-05	0.000205	CcSEcCtD
Adenosine—Dermatitis—Methotrexate—breast cancer	3.23e-05	0.000205	CcSEcCtD
Adenosine—Headache—Methotrexate—breast cancer	3.21e-05	0.000204	CcSEcCtD
Adenosine—Asthenia—Doxorubicin—breast cancer	3.18e-05	0.000202	CcSEcCtD
Adenosine—Dizziness—Epirubicin—breast cancer	3.17e-05	0.000201	CcSEcCtD
Adenosine—Vomiting—Epirubicin—breast cancer	3.05e-05	0.000193	CcSEcCtD
Adenosine—Nausea—Methotrexate—breast cancer	3.04e-05	0.000193	CcSEcCtD
Adenosine—Rash—Epirubicin—breast cancer	3.02e-05	0.000192	CcSEcCtD
Adenosine—Dermatitis—Epirubicin—breast cancer	3.02e-05	0.000192	CcSEcCtD
Adenosine—Headache—Epirubicin—breast cancer	3e-05	0.00019	CcSEcCtD
Adenosine—Dizziness—Doxorubicin—breast cancer	2.93e-05	0.000186	CcSEcCtD
Adenosine—Nausea—Epirubicin—breast cancer	2.85e-05	0.000181	CcSEcCtD
Adenosine—Vomiting—Doxorubicin—breast cancer	2.82e-05	0.000179	CcSEcCtD
Adenosine—Rash—Doxorubicin—breast cancer	2.8e-05	0.000177	CcSEcCtD
Adenosine—Dermatitis—Doxorubicin—breast cancer	2.79e-05	0.000177	CcSEcCtD
Adenosine—Headache—Doxorubicin—breast cancer	2.78e-05	0.000176	CcSEcCtD
Adenosine—Nausea—Doxorubicin—breast cancer	2.63e-05	0.000167	CcSEcCtD
Adenosine—Adenosine triphosphate—ABCB1—breast cancer	2.24e-05	0.00305	CrCbGaD
Adenosine—ADA—Metabolism—ALB—breast cancer	1.11e-05	9.14e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RPS6—breast cancer	1.1e-05	9.09e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SMAD4—breast cancer	1.1e-05	9.09e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1R—breast cancer	1.1e-05	9.03e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF4—breast cancer	1.1e-05	9.02e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL8—breast cancer	1.09e-05	8.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCR4—breast cancer	1.09e-05	8.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL12—breast cancer	1.09e-05	8.99e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—AKT1—breast cancer	1.09e-05	8.99e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FGFR1—breast cancer	1.08e-05	8.88e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HES1—breast cancer	1.08e-05	8.87e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PAK1—breast cancer	1.07e-05	8.82e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NCOR1—breast cancer	1.07e-05	8.82e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PLA2G4A—breast cancer	1.07e-05	8.82e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HIF1A—breast cancer	1.06e-05	8.74e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—NOS3—breast cancer	1.06e-05	8.74e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CSF2—breast cancer	1.06e-05	8.72e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGF1—breast cancer	1.06e-05	8.72e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—RAF1—breast cancer	1.06e-05	8.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TCF7L2—breast cancer	1.05e-05	8.67e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NRG1—breast cancer	1.05e-05	8.66e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT2—breast cancer	1.05e-05	8.63e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—H2AFX—breast cancer	1.04e-05	8.6e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—breast cancer	1.04e-05	8.59e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CG—breast cancer	1.04e-05	8.56e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—LEP—breast cancer	1.04e-05	8.54e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—E2F1—breast cancer	1.04e-05	8.54e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CB—breast cancer	1.03e-05	8.5e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CAV1—breast cancer	1.03e-05	8.46e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KDR—breast cancer	1.02e-05	8.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH2—breast cancer	1.01e-05	8.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HSP90AA1—breast cancer	1.01e-05	8.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CD—breast cancer	1.01e-05	8.29e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SPP1—breast cancer	9.96e-06	8.2e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL8—breast cancer	9.92e-06	8.16e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ESR1—breast cancer	9.9e-06	8.15e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PRL—breast cancer	9.87e-06	8.13e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AGTR1—breast cancer	9.87e-06	8.13e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB3—breast cancer	9.85e-06	8.11e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR2—breast cancer	9.84e-06	8.1e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CB—breast cancer	9.8e-06	8.07e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—FN1—breast cancer	9.78e-06	8.05e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STK11—breast cancer	9.73e-06	8.01e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ADAM10—breast cancer	9.73e-06	8.01e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTGS2—breast cancer	9.71e-06	8e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NFKBIA—breast cancer	9.66e-06	7.95e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PLG—breast cancer	9.62e-06	7.92e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOTCH1—breast cancer	9.57e-06	7.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT2—breast cancer	9.51e-06	7.83e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—breast cancer	9.48e-06	7.8e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF10—breast cancer	9.46e-06	7.79e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TERT—breast cancer	9.44e-06	7.77e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CG—breast cancer	9.36e-06	7.7e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KIT—breast cancer	9.36e-06	7.7e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APC—breast cancer	9.36e-06	7.7e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGF—breast cancer	9.25e-06	7.61e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FGFR1—breast cancer	9.17e-06	7.55e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CD—breast cancer	9.14e-06	7.53e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PDGFA—breast cancer	9.13e-06	7.52e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HIF1A—breast cancer	9.03e-06	7.44e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFBR2—breast cancer	9e-06	7.41e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK3—breast cancer	8.96e-06	7.38e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ITPR1—breast cancer	8.86e-06	7.29e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LEP—breast cancer	8.81e-06	7.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB4—breast cancer	8.8e-06	7.24e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT5A—breast cancer	8.8e-06	7.24e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP3—breast cancer	8.8e-06	7.24e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—BRAF—breast cancer	8.79e-06	7.24e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—PIK3CA—breast cancer	8.79e-06	7.24e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CB—breast cancer	8.77e-06	7.22e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CAV1—breast cancer	8.73e-06	7.19e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KDR—breast cancer	8.64e-06	7.11e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IGF1—breast cancer	8.57e-06	7.05e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT2—breast cancer	8.56e-06	7.05e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—EGFR—breast cancer	8.52e-06	7.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SMAD4—breast cancer	8.52e-06	7.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1R—breast cancer	8.47e-06	6.97e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PTEN—breast cancer	8.47e-06	6.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL8—breast cancer	8.43e-06	6.94e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ESR1—breast cancer	8.42e-06	6.93e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HES1—breast cancer	8.32e-06	6.85e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—FN1—breast cancer	8.31e-06	6.84e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NCOR1—breast cancer	8.27e-06	6.81e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PLA2G4A—breast cancer	8.27e-06	6.81e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CD—breast cancer	8.22e-06	6.77e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NFKBIA—breast cancer	8.21e-06	6.76e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGF1—breast cancer	8.18e-06	6.73e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CSF2—breast cancer	8.18e-06	6.73e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RAF1—breast cancer	8.16e-06	6.72e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PIK3CA—breast cancer	8.15e-06	6.71e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SERPINE1—breast cancer	8.13e-06	6.7e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOTCH1—breast cancer	8.13e-06	6.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NRG1—breast cancer	8.12e-06	6.69e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—H2AFX—breast cancer	8.06e-06	6.64e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—breast cancer	8.06e-06	6.63e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—KRAS—breast cancer	8.05e-06	6.63e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—E2F1—breast cancer	8e-06	6.59e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CB—breast cancer	7.97e-06	6.56e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CG—breast cancer	7.95e-06	6.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APC—breast cancer	7.95e-06	6.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KIT—breast cancer	7.95e-06	6.55e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGF—breast cancer	7.86e-06	6.47e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—NOS3—breast cancer	7.77e-06	6.39e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SPP1—breast cancer	7.69e-06	6.33e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL8—breast cancer	7.66e-06	6.3e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK3—breast cancer	7.62e-06	6.27e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB3—breast cancer	7.61e-06	6.26e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR2—breast cancer	7.59e-06	6.25e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—BRAF—breast cancer	7.48e-06	6.16e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PIK3CA—breast cancer	7.4e-06	6.09e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MDM2—breast cancer	7.37e-06	6.07e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RAF1—breast cancer	7.34e-06	6.05e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—breast cancer	7.32e-06	6.02e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RELA—breast cancer	7.31e-06	6.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TERT—breast cancer	7.29e-06	6e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IGF1—breast cancer	7.28e-06	6e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT2—breast cancer	7.28e-06	5.99e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ERBB2—breast cancer	7.26e-06	5.98e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—EGFR—breast cancer	7.25e-06	5.97e-05	CbGpPWpGaD
Adenosine—ADK—Metabolism—AKT1—breast cancer	7.18e-06	5.91e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MTOR—breast cancer	7.17e-06	5.9e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CB—breast cancer	7.17e-06	5.9e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FGFR1—breast cancer	7.08e-06	5.83e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CD—breast cancer	6.99e-06	5.76e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HIF1A—breast cancer	6.97e-06	5.74e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PIK3CA—breast cancer	6.93e-06	5.7e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SERPINE1—breast cancer	6.92e-06	5.7e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL8—breast cancer	6.89e-06	5.67e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—KRAS—breast cancer	6.85e-06	5.64e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—HRAS—breast cancer	6.84e-06	5.64e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—LEP—breast cancer	6.81e-06	5.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CAV1—breast cancer	6.74e-06	5.55e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1B—breast cancer	6.73e-06	5.54e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KDR—breast cancer	6.67e-06	5.49e-05	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—AKT1—breast cancer	6.65e-06	5.48e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—NOS3—breast cancer	6.6e-06	5.44e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CASP3—breast cancer	6.59e-06	5.43e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—breast cancer	6.58e-06	5.42e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—breast cancer	6.55e-06	5.39e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ESR1—breast cancer	6.5e-06	5.35e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCND1—breast cancer	6.42e-06	5.28e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—FN1—breast cancer	6.42e-06	5.28e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—JUN—breast cancer	6.4e-06	5.27e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CTNNB1—breast cancer	6.36e-06	5.23e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NFKBIA—breast cancer	6.34e-06	5.22e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PIK3CA—breast cancer	6.29e-06	5.18e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOTCH1—breast cancer	6.28e-06	5.17e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MDM2—breast cancer	6.26e-06	5.16e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RAF1—breast cancer	6.24e-06	5.14e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—breast cancer	6.23e-06	5.13e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RELA—breast cancer	6.22e-06	5.12e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CDKN1A—breast cancer	6.21e-06	5.11e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTEN—breast cancer	6.19e-06	5.1e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ERBB2—breast cancer	6.18e-06	5.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APC—breast cancer	6.14e-06	5.06e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KIT—breast cancer	6.14e-06	5.06e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CG—breast cancer	6.14e-06	5.06e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CB—breast cancer	6.1e-06	5.02e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MTOR—breast cancer	6.1e-06	5.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGF—breast cancer	6.07e-06	5e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK8—breast cancer	6.06e-06	4.99e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—AKT1—breast cancer	6.04e-06	4.98e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—PIK3CA—breast cancer	5.97e-06	4.92e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK3—breast cancer	5.88e-06	4.84e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL8—breast cancer	5.86e-06	4.82e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—HRAS—breast cancer	5.82e-06	4.79e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—BRAF—breast cancer	5.77e-06	4.75e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SRC—breast cancer	5.74e-06	4.73e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1B—breast cancer	5.72e-06	4.71e-05	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—AKT1—breast cancer	5.66e-06	4.66e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IGF1—breast cancer	5.62e-06	4.63e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT2—breast cancer	5.62e-06	4.63e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CASP3—breast cancer	5.61e-06	4.62e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—breast cancer	5.6e-06	4.61e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—EGFR—breast cancer	5.6e-06	4.61e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—VEGFA—breast cancer	5.6e-06	4.61e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—breast cancer	5.57e-06	4.59e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—breast cancer	5.54e-06	4.56e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCND1—breast cancer	5.46e-06	4.49e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—JUN—breast cancer	5.45e-06	4.48e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CTNNB1—breast cancer	5.4e-06	4.45e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CD—breast cancer	5.4e-06	4.45e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PIK3CA—breast cancer	5.35e-06	4.4e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SERPINE1—breast cancer	5.34e-06	4.4e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—breast cancer	5.3e-06	4.36e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK3—breast cancer	5.29e-06	4.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—KRAS—breast cancer	5.29e-06	4.35e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CDKN1A—breast cancer	5.28e-06	4.35e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTEN—breast cancer	5.27e-06	4.34e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK8—breast cancer	5.15e-06	4.24e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—breast cancer	5.15e-06	4.24e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—AKT1—breast cancer	5.14e-06	4.23e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—breast cancer	5.14e-06	4.23e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—NOS3—breast cancer	5.1e-06	4.2e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—EGFR—breast cancer	5.04e-06	4.15e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SRC—breast cancer	4.88e-06	4.02e-05	CbGpPWpGaD
Adenosine—ADA—Metabolism—AKT1—breast cancer	4.88e-06	4.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PIK3CA—breast cancer	4.86e-06	4e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MDM2—breast cancer	4.84e-06	3.98e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RAF1—breast cancer	4.82e-06	3.97e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RELA—breast cancer	4.8e-06	3.95e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ERBB2—breast cancer	4.77e-06	3.93e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—VEGFA—breast cancer	4.76e-06	3.92e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—KRAS—breast cancer	4.76e-06	3.92e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—breast cancer	4.71e-06	3.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CB—breast cancer	4.71e-06	3.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MTOR—breast cancer	4.71e-06	3.88e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL8—breast cancer	4.52e-06	3.72e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK3—breast cancer	4.5e-06	3.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—HRAS—breast cancer	4.49e-06	3.7e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1B—breast cancer	4.42e-06	3.64e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—breast cancer	4.38e-06	3.6e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PIK3CA—breast cancer	4.37e-06	3.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—AKT1—breast cancer	4.37e-06	3.6e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—breast cancer	4.37e-06	3.6e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CASP3—breast cancer	4.33e-06	3.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—breast cancer	4.32e-06	3.56e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—breast cancer	4.3e-06	3.54e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—EGFR—breast cancer	4.28e-06	3.53e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TP53—breast cancer	4.23e-06	3.48e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCND1—breast cancer	4.21e-06	3.47e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—JUN—breast cancer	4.2e-06	3.46e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CTNNB1—breast cancer	4.17e-06	3.44e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—breast cancer	4.09e-06	3.37e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CDKN1A—breast cancer	4.08e-06	3.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTEN—breast cancer	4.07e-06	3.35e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—KRAS—breast cancer	4.04e-06	3.33e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—HRAS—breast cancer	4.04e-06	3.33e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK8—breast cancer	3.98e-06	3.28e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—AKT1—breast cancer	3.97e-06	3.27e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—breast cancer	3.87e-06	3.19e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SRC—breast cancer	3.77e-06	3.11e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PIK3CA—breast cancer	3.72e-06	3.06e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—VEGFA—breast cancer	3.67e-06	3.02e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—breast cancer	3.64e-06	2.99e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TP53—breast cancer	3.59e-06	2.96e-05	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—AKT1—breast cancer	3.57e-06	2.94e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK3—breast cancer	3.47e-06	2.86e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—HRAS—breast cancer	3.44e-06	2.83e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—breast cancer	3.38e-06	2.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—breast cancer	3.37e-06	2.78e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—EGFR—breast cancer	3.31e-06	2.72e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—breast cancer	3.29e-06	2.71e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—KRAS—breast cancer	3.12e-06	2.57e-05	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—AKT1—breast cancer	3.04e-06	2.5e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PIK3CA—breast cancer	2.87e-06	2.36e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TP53—breast cancer	2.78e-06	2.29e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—HRAS—breast cancer	2.65e-06	2.19e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—breast cancer	2.54e-06	2.09e-05	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—AKT1—breast cancer	2.34e-06	1.93e-05	CbGpPWpGaD
